Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
11.85
-0.55 (-4.44%)
Nov 20, 2026, 3:04 PM CST
SHE:002675 Revenue
Yantai Dongcheng Pharmaceutical Group had revenue of 626.09M CNY in the quarter ending September 30, 2026, a decrease of -5.05%. This brings the company's total for the last twelve months to 2.63B, down -4.24% year-over-year. In the year 2025, Yantai Dongcheng Pharmaceutical Group had annual revenue of 2.74B, down -4.46%. That makes Yantai Dongcheng Pharmaceutical Group the 12,726th largest company in the world by revenue and 2,207th in China.
Revenue (ttm)
2.63B
Revenue Growth
-4.24%
P/S Ratio
3.71
Revenue / Employee
1.02M
Employees
2,583
Market Cap
9.77B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHE:002675 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.74B | -127.86M | -4.46% |
| Dec 31, 2024 | 2.87B | -406.71M | -12.42% |
| Dec 31, 2023 | 3.28B | -307.31M | -8.58% |
| Jan 1, 2023 | 3.58B | -329.09M | -8.41% |
| Jan 1, 2022 | 3.91B | 493.07M | 14.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Medicine | 8.43B |
| Shanghai Shyndec Pharmaceutical | 8.03B |
| Zhejiang CONBA Pharmaceutical | 6.83B |
| Zhejiang Jingxin Pharmaceutical | 4.06B |
| Mayinglong Pharmaceutical Group | 3.99B |
| Porton Pharma Solutions | 3.64B |
| PharmaBlock Sciences (Nanjing) | 2.19B |
| Beijing Aosaikang Pharmaceutical | 1.59B |